Treatment of Acute Aortic Insufficiency With a Dedicated Device

A 66-year-old man with refractory multiple myeloma presented with acute severe aortic insufficiency leading to cardiogenic shock and multiorgan failure. After comprehensive heart team evaluation, he underwent successful JenaValve transcatheter aortic valve (JenaValve Technology, Inc., Irvine, Califo...

Full description

Bibliographic Details
Main Authors: Vivian G. Ng, MD, Omar K. Khalique, MD, Tamim Nazif, MD, Amisha Patel, MD, Nadira Hamid, MD, Isaac George, MD, Vinayak Bapat, MD, Rebecca Hahn, MD, Susheel Kodali, MD, Torsten P. Vahl, MD
Format: Article
Language:English
Published: Elsevier 2021-04-01
Series:JACC: Case Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2666084921001200
Description
Summary:A 66-year-old man with refractory multiple myeloma presented with acute severe aortic insufficiency leading to cardiogenic shock and multiorgan failure. After comprehensive heart team evaluation, he underwent successful JenaValve transcatheter aortic valve (JenaValve Technology, Inc., Irvine, California) implantation resulting in resolution of his aortic insufficiency and improvement in his clinical status. (Level of Difficulty: Advanced.)
ISSN:2666-0849